References
- De Bartolomeis C, Collini A, Rumberger B, et al. Generalized lymphedema in a sirolimus-treated renal transplant patient. Clin Transplant 2008;22(02):254-257 https://doi.org/10.1111/j.1399-0012.2007.00766.x
- Kim J, Jeon JY, Ko YM, Kang MS, Park SK, Roh K. Characteristics of lymphedema in patients treated with mammalian target of rapamycin inhibitors. Lymphat Res Biol 2021;19(04):365-371 https://doi.org/10.1089/lrb.2020.0069
- Nguyen LS, Vautier M, Allenbach Y, et al. Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation. Drug Saf 2019;42(07):813-825 https://doi.org/10.1007/s40264-019-00810-9
- Daniell KM, Bardia A, Sun F, et al. Incidence of peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for metastatic breast cancer. Breast Cancer Res Treat 2019;175(03):649-658 https://doi.org/10.1007/s10549-019-05206-y
- Desai N, Heenan S, Mortimer PS. Sirolimus-associated lymphoedema: eight new cases and a proposed mechanism. Br J Dermatol 2009;160(06):1322-1326 https://doi.org/10.1111/j.1365-2133.2009.09098.x
- Kerjaschki D. How to control lymphangiogenesis: a novel role for rapamycin. Kidney Int 2007;71(08):717-719 https://doi.org/10.1038/sj.ki.5002184
- Huber S, Bruns CJ, Schmid G, et al. Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int 2007;71(08):771-777 https://doi.org/10.1038/sj.ki.5002112
- Ardalan MR. Lymphedema attributed to sirolimus. J Nephropharmacol 2013;2(02):35-36
- Al GainM, Crickx B, Bejar C, et al. [Sirolimus-inducedlymphedema in a kidney-transplant recipient: partial recovery after changeover to tacrolimus]. Ann Dermatol Venereol 2015;142(05):350-355French.
- Fourgeaud C, Simon L, Benoughidane B, Vignes S. Lymphedema in patients treated with sirolimus: 15 cases [in French]. Rev Med Interne 2019;40(03):151-157 https://doi.org/10.1016/j.revmed.2018.04.018
- Romagnoli J, Citterio F, Nanni G, Tondolo V, Castagneto M. Severe limb lymphedema in sirolimus-treated patients. Transplant Proc 2005;37(02):834-836 https://doi.org/10.1016/j.transproceed.2004.12.180
- Chang DW, Masia J, Garza R III, Skoracki R, Neligan PC. Lymphedema: surgical and medical therapy. Plast Reconstr Surg 2016; 138(03):209S-218S https://doi.org/10.1097/PRS.0000000000002683
- Kwon JG, Hong DW, Suh HP, Pak CJ, Hong JP. Patient-specific surgical options for breast cancer-related lymphedema: technical tips. Arch Plast Surg 2021;48(03):246-253 https://doi.org/10.5999/aps.2020.02432
- Beederman M, Chang DW. Advances in surgical treatment of lymphedema. Arch Plast Surg 2021;48(06):670-677 https://doi.org/10.5999/aps.2021.01445
- Torio-Padron N, Stark GB, Foldi E, Simunovic F. Treatment of male genital lymphedema: an integrated concept. J Plast Reconstr Aesthet Surg 2015;68(02):262-268 https://doi.org/10.1016/j.bjps.2014.10.003
- Czedik-Eysenberg M, Steinbacher J, Obermayer B, et al. Exclusive use of ultrasound for locating optimal LVA sites-a descriptive data analysis. J Surg Oncol 2020;121(01):51-56 https://doi.org/10.1002/jso.25728
- Mohos B, Czedik-Eysenberg M, Steinbacher J, Tinhofer I, Meng S, Tzou CJ. Long-term use of ultrasound for locating optimal LVA sites: a descriptive data analysis. J Reconstr Microsurg 2022;38(03):238-244 https://doi.org/10.1055/s-0041-1740124
- Kim L, Jeon JY, Sung IY, Jeong SY, Do JH, Kim HJ. Prediction of treatment outcome with bioimpedance measurements in breast cancer related lymphedema patients. Ann Rehabil Med 2011;35(05):687-693 https://doi.org/10.5535/arm.2011.35.5.687
- van Heumen S, Riksen JJM, Bramer WM, van Soest G, Vasilic D. Imaging of the lymphatic vessels for surgical planning: a systematic review. Ann Surg Oncol 2023;30(01):462-479 https://doi.org/10.1245/s10434-022-12552-7
- Oh A, Kajita H, Matoba E, et al. Photoacoustic lymphangiography before and after lymphaticovenular anastomosis. Arch Plast Surg 2021;48(03):323-328 https://doi.org/10.5999/aps.2020.02404